Role of nitric oxide on the vasorelaxant effect of atrial natriuretic peptide on rabbit aorta basal tone

Canadian Journal of Physiology and Pharmacology

Volumn 80, Issue 10, 2002, Pages 1022-1029

  Romano, Liliana ^a   Coviello, Alfredo ^a   Jerez, Susana ^a   Peral de Bruno, María ^a  

^a UNIVERSIDAD NACIONAL DE TUCUMÁN   (Argentina)

Author keywords

Atrial natriuretic peptide; Basal tone; Nitric oxide; Rabbit aorta; Vascular reactivity

Indexed keywords

ANGIOTENSIN; ATRIAL NATRIURETIC FACTOR; METHYLENE BLUE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; ANGIOTENSIN II; ENZYME INHIBITOR; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY TONE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; DRUG SENSITIZATION; FEMALE; HORMONAL REGULATION; HORMONE DETERMINATION; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; THORACIC AORTA; VASCULAR ENDOTHELIUM; VASCULAR RING; VASODILATATION; ANIMAL; COMPARATIVE STUDY; IN VITRO STUDY; METABOLISM; PHYSIOLOGY; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN II; ANIMALS; AORTA, THORACIC; ATRIAL NATRIURETIC FACTOR; ENZYME INHIBITORS; FEMALE; MALE; MUSCLE, SMOOTH, VASCULAR; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; RABBITS; VASOCONSTRICTOR AGENTS; VASODILATION; VASODILATOR AGENTS;

EID: 1842833013     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y02-130     Document Type: Article

References (42)

1. Chinkers, M., Garbers, D.L., Chang, M.S., Lowe, D.G., Chin, H., Goeddel, D.V., and Schulz, S. 1989. A membrane from guanylate cyclase is an atrial natriuretic peptide receptor. Nature (Lond.), 338: 78-83.
2. Costa, M.A., Gonzalez Bosc, L.V., Majowicz, M.P., Vidal, N.A., Balaszczuk, A.M., and Arranz, C.T. 2000. Atrial natriuretic peptide modifies arterial blood pressure through nitric oxide pathway in rats. Hypertension, 35: 1119-1123.
3. De Bold, A.J., Borenstein, H.B., Veress, A.T., and Sonnenberg, H.A. 1981. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci. 28: 89-94.
4. Dellipizzi, A., Pucci, M.L., Monsy, A.Y., Deseyn, K., and Nasjletti, A. 1997. Contribution of the prostanoids to calcium-dependent basal tone in the aorta from rats with aortic coarctation-induced hypertension: Relationship to nitric oxide. J. Pharmacol. Exp. Ther. 283: 75-81.
5. Deng, X., Welch, W.J., and Wilcox, C.S. 1996. Role of nitric oxide in short-term and prolonged effects of angiotensin II on renal hemodynamics. Hypertension, 27: 1173-1179.
6. Ferrer, M., Alonso, M.J., Salaices, M., Marín, J., and Balfagón, G. 2001. Angiotensin II increases neurogenic nitric oxide metabolism in mesenteric arteries from hypertensive rats. Life Sci. 68: 1169-1179.
7. Furchgott, R.F. 1983. Role of endothelium in the responses of vascular smooth muscle. Circ. Res. 53: 557-573.
8. Garcia, R., Thibault, G., Genest, J., and Cantin, M. 1984. Effect of a purified atrial natriuretic factor on rat and rabbit strips and vascular beds. Am. J. Physiol. 247: R34-R39.
9. Griendling, K.K., Minieri, C.A., Ollerenshaw, J.D., and Alexander, R.W. 1994. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ. Res. 74: 1141-1148.
10. Hennington, B.S., Zhang, H., Miller, M.T., Granger, J.P., and Reckelhoff, J.F. 1998. Angiotensin II stimulates synthesis of endothelial nitric oxide synthase. Hypertension, 31(Part 2): 283-288.
11. Ito, S., Johnson, C.S., and Carretero, O.A. 1991. Modulation of angiotensin II-induced vasoconstriction by endothelium-derived relaxing factor in the isolated microperfused rabbit afferent arteriole. J. Clin. Invest. 87: 1656-1663.
12. Jerez, S., Peral de Bruno, M., and Coviello, A. 2001a. Endothelium-dependent desensitization to angiotensin II in rabbit aorta: Mechanisms involved. Can. J. Physiol. Pharmacol. 79: 481-489.
13. 2 adrenérgicos sobre la liberación de oxido nítrico (ON) inducida por angiotensina. Medicina, 61: 431-436.
14. Lee, J., Ishiara, A., Oxford, G., Johnson, B., and Jacobson, K. 1999. Regulation of cell movement is mediated by stretch-activated calcium channels. Nature (Lond.), 6742: 382-386.
15. Levin, E.R., Gardner, D.G., and Samson, W.K. 1998. Natriuretic peptides. N. Engl. J. Med. 339: 321-328.
16. Meisheri, K.D., Taylor, C.J., and Saneii, H. 1986. Synthetic atrial peptide inhibits intracellular calcium release in smooth muscle. Am. J. Physiol. 25: C171-C174.
17. Naruse, K., Yamada, T., and Sokabe, M. 1998. Involvement of SA channels in orienting response of cultured endothelial cells to cyclic stretch. Am. J. Physiol. 274: H1532-H1538.
18. Pagano, P.J., Clark, J.K., Cifuentes-Pagano, M.E., Clark, S.M., Callis, G.M., and Quinn, M.T. 1997. Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: Enhancement by angiotensin II. Proc. Natl. Acad. Sci. U.S.A. 94: 14 483 - 14 488.
19. phox mRNA expresión and NADPH oxidase superoxide generation in rabbit aortic adventitial fibroblasts. Hypertension, 32: 331-337.
20. Palmer, R.M., Ferridge, A.G., and Moncada, S. 1987. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature (Lond.), 327: 524-526.
21. Palmer, R.M., Ashton, D.S., and Moncada, S. 1988. Endothelial cells synthesize nitric oxide from L-arginine. Nature (Lond.), 333: 664-666.
22. Peral de Bruno, M., and Coviello, A. 1992. Effects of atrial natriuretic peptide and toad heart extract on isolated toad Bufo arenarum aortic rings. Gen. Comp. Endocrinol. 88: 424-433.
23. Peral de Bruno, M., Coviello, A., Meyer, M., and Forssmann, W.G. 1992. Relaxation of non-contracted smooth muscle by atrial natriuretic peptide. Clin. Exp. Hypertens. Part A Theory Pract. 14: 1125-1139.
24. Peral de Bruno, M., Romano, L., and Coviello, A. 1999a. Losartan reduces the vasorelaxant effect of atrial natriuretic peptide on basal tone in aorta. Clin. Exp. Hypertens. Part A Theory Pract. 21: 1257-1271.
25. Peral de Bruno, M., Romano, L., Proto, M., and Coviello, A. 1999b. Atrial natriuretic peptide relaxes arterial basal tone induced by coarctation hypertension. Peptides, 20: 485-491.
26. Privat, C., Lantoine, F., Bedioui, F., Millanvoye van Brussel, E.R., Devynck, J., and Devynck, M.A. 1997. Nitric oxide production by endothelial cells: Comparison of three methods of quantification. Life Sci. 61: 1193-1202.
27. Pucci, M.L., Miller, K.B., Dick, L.B., Guan, H., Lin, L., and Nasjletti, A. 1994. Vascular responsiveness to nitric oxide synthesis inhibition in hypertensive rats. Hypertension, 23: 744-751.
28. Pucci, M.L., Tong, X., Miller, K.B., Guan, H., Lin, L., and Nasjletti, A. 1995. Calcium- and protein kinase C-dependent basal tone in the aorta of hypertensive rats. Hypertension, 25: 752-757.
29. Rajagopalan, S., Kurz, S., Münzel, T., Tarpey, M., Freeman, B.A., Griedling, K.K., and Harrison, D.G. 1996. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. J. Clin. Invest. 97: 1916-1923.
30. 2+ influx modulated by stretch in A7r5 vascular smooth muscle cells. Eur. J. Pharmacol. 296: 327-334.
31. Saye, J.A., Singer, H.A., and Peach, M.J. 1984. Role of endothelium in conversion of angiotensin I to angiotensin II in rabbit aorta. Hypertension, 6: 216-221.
32. Schulz, S., and Waldmann, S.A. 1999. The guanylyl cyclase of natriuretic peptide receptors. Vitam. Horm. 57: 123-151.
33. Seyedi, N., Xu, X.B., Nasjletti, A., and Hintze, T.H. 1995. Coronary kinin generation mediates nitric oxide release after angiotensin receptor stimulation. Hypertension, 26: 164-170.
34. Simonsen, U., Wadsworth, R.M., Buus, N.H., and Mulvany, M.J. 1999. In vitro simultaneous measurements of relaxation and nitric oxide concentration in rat superior mesenteric artery. J. Physiol. 516: 271-282.
35. 2+ from intracellular storage sites in canine cerebral arteries. Can. J. Physiol. Pharmacol. 72: 19-24.
36. Tanaka, I., Aida, M., Tanaka, H., Shigenobu, K., and Toro, L. 1998. Involvement of maxi-K (Ca) channel activation in atrial natriuretic peptide-induced vasorelaxation. Naunyn-Schmiedeberg's Arch. Pharmacol. 35: 705-708.
37. Waldmann, S.A., and Munrad, F. 1989. Atrial natriuretic peptide receptors and second messengers. Bioassays, 10: 16-19.
38. 2 receptors in endothelial cells and isolated ischemic rat hearts. J. Hypertens. 5: S234-S235.
39. Winquist, R.J., Faison, E.P., Waldman, S.A., Schwartz, K., Murad, F., and Rapoport, R.M. 1984. Atrial natriuretic factor elicits an endothelium-independent relaxation and activates particulate guanylate cyclase in vascular smooth muscle. Proc. Natl. Acad. Sci. U.S.A. 81: 7761-7764.
40. Zhang, J., Van Meel, J.C.A., Pfaffendorf, M., Zhang, J.S., and Van Zwieten, P.A. 1994. Endothelium-dependent, nitric oxide-mediated inhibition of angiotensin II-induced contractions in rabbit aorta. Eur. J. Pharmacol. 262: 247-253.
41. Zhang, J., Pfaffendorf, M., Zhang, J.S., and Van Zwieten, P.A. 1995. Influence of the vascular endothelium on angiotensin II-induced contractions in rabbit renal artery. Fundam. Clin. Pharmacol. 9: 25-29.
42. Zhang, X., Nasjletti, A., Xu, X., and Hintze, T.H. 1998. Neutral endopeptidase and angiotensin-converting enzyme inhibitors increase nitric oxide production in isolated canine coronary microvessels by a kinin-dependent mechanism. J. Cardiovasc. Pharmacol. 31: 623-629.